Analyzing the correlation between eIF4G1 expression and clinicopathological features, we observed that eIF4G1 expression in early stages of ovarian cancer according to FIGO staging is significantly lower than in advanced stages. This evidence concerns the gene EIF4G1 and ovarian carcinoma.